CD33 and colorectal cancer: However, another studies showed that higher level of circulating HLA-DR−CD11b+CD33+ population was correlated with advanced stages and lymph node metastases (38) and greater abundance of circulating Lin−/lowHLA-DR−CD11b+CD33+ cells was correlated with stage and tumor metastasis but not primary tumor size in colorectal cancer (39).